| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |